GILEAD
LIVE

Serial Number

88352036

Owner

Gilead Sciences, Inc.

Attorney

Gretchen R. Stroud

First Use Date

Jul 31, 2004

Filing Date

Mar 22, 2019

Add to watchlist:

No watchlists yet
View on USPTO

GILEAD Trademark

Serial Number: 88352036 • Registration: 6325064

GILEAD is a trademark filed by Gilead Sciences, Inc. on March 22, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Gilead Sciences, Inc. (4 trademarks)

333 Lakeside Drive
Foster City, CA 94404

Entity Type: 03

Trademark Details

Filing Date

March 22, 2019

Registration Date

April 20, 2021

First Use Anywhere

July 31, 2004

First Use in Commerce

July 31, 2004

Published for Opposition

February 2, 2021

Goods & Services

Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; counseling and charitable services for patients, namely, providing information and assistance with respect to obtaining prescription medications

Pharmaceutical preparations, namely, pharmaceuticals for the treatment of viral infections; pharmaceuticals for the treatment of cardiovascular disorders and conditions; pharmaceuticals for the treatment of respiratory disorders and conditions; pharmaceuticals for the treatment of fungal diseases and disorders; pharmaceuticals for the treatment of liver disease; pharmaceuticals for the treatment of HIV/AIDS and hepatitis; pharmaceuticals for the treatment of inflammatory diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapy, including T Cell therapy

Financial sponsorship of sports, educational and entertainment programs and events; financial administration of patient reimbursement programs

Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy

Educational services, namely, conducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 20, 2026 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 7, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 7, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Apr 20, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2020 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 25, 2020 RCSC
ASSIGNED TO LIE
Jun 25, 2020 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 25, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 25, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 25, 2019 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 24, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 24, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jun 24, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2019 CRFA
ASSIGNED TO LIE
Jun 18, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 9, 2019 NWOS
NEW APPLICATION ENTERED
Mar 26, 2019 NWAP